Literature DB >> 17628290

A-to-I editing challenger or ally to the microRNA process.

M Ohman1.   

Abstract

Adenosine to inosine (A-to-I) modification by the ADAR (adenosine deaminase that acts on RNA) enzymes perform the most common type of RNA editing in metazoans. ADARs use double stranded RNA as substrates but allow interruptions of bulges and loops in the structure. It is well known that these enzymes can use messenger RNA as targets for A-to-I editing and thereby recode the transcript. Both ADAR1 and ADAR2 have been proven to be able to also target short double stranded RNA molecules of the same size as a microRNA. However, it is not until recently shown that A-to-I editing occurs in microRNAs and its precursors. Since the editing activity is found both in the nucleus and the cytoplasm there are several steps during the microRNA maturation pathway that can be targeted for modification. This review will give an overview of what is known today about the interactions between the endogenous RNA interference process and RNA editing. It will also give some insight into the power of A-to-I modification in its ability to increase the variety of microRNA gene silencing.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17628290     DOI: 10.1016/j.biochi.2007.06.002

Source DB:  PubMed          Journal:  Biochimie        ISSN: 0300-9084            Impact factor:   4.079


  27 in total

Review 1.  The use of high-throughput sequencing methods for plant microRNA research.

Authors:  Xiaoxia Ma; Zhonghai Tang; Jingping Qin; Yijun Meng
Journal:  RNA Biol       Date:  2015       Impact factor: 4.652

Review 2.  ADAR proteins: double-stranded RNA and Z-DNA binding domains.

Authors:  Pierre Barraud; Frédéric H-T Allain
Journal:  Curr Top Microbiol Immunol       Date:  2012       Impact factor: 4.291

3.  Mature and immature microRNA ratios in cultured rat cardiomyocytes during anoxia-reoxygenation.

Authors:  Victor E Dosenko; Veronika L Gurianova; Olga V Surova; Dmitriy A Stroy; Alex A Moibenko
Journal:  Exp Clin Cardiol       Date:  2012

4.  Drosha as an interferon-independent antiviral factor.

Authors:  Jillian S Shapiro; Sonja Schmid; Lauren C Aguado; Leah R Sabin; Ari Yasunaga; Jaehee V Shim; David Sachs; Sara Cherry; Benjamin R tenOever
Journal:  Proc Natl Acad Sci U S A       Date:  2014-04-28       Impact factor: 11.205

5.  Alu sequences in undifferentiated human embryonic stem cells display high levels of A-to-I RNA editing.

Authors:  Sivan Osenberg; Nurit Paz Yaacov; Michal Safran; Sharon Moshkovitz; Ronit Shtrichman; Ofra Sherf; Jasmine Jacob-Hirsch; Gilmor Keshet; Ninette Amariglio; Joseph Itskovitz-Eldor; Gideon Rechavi
Journal:  PLoS One       Date:  2010-06-21       Impact factor: 3.240

6.  Analysis of microRNA expression in the prepubertal testis.

Authors:  Gregory M Buchold; Cristian Coarfa; Jong Kim; Aleksandar Milosavljevic; Preethi H Gunaratne; Martin M Matzuk
Journal:  PLoS One       Date:  2010-12-29       Impact factor: 3.240

7.  Dysregulated A to I RNA editing and non-coding RNAs in neurodegeneration.

Authors:  Minati Singh
Journal:  Front Genet       Date:  2013-01-22       Impact factor: 4.599

Review 8.  Regulatory roles of natural antisense transcripts.

Authors:  Mohammad Ali Faghihi; Claes Wahlestedt
Journal:  Nat Rev Mol Cell Biol       Date:  2009-07-29       Impact factor: 94.444

9.  MicroRNA: Implications for Alzheimer Disease and other Human CNS Disorders.

Authors:  Olivier C Maes; Howard M Chertkow; Eugenia Wang; Hyman M Schipper
Journal:  Curr Genomics       Date:  2009-05       Impact factor: 2.236

Review 10.  Regulation of microRNA processing in development, differentiation and cancer.

Authors:  Thomas D Schmittgen
Journal:  J Cell Mol Med       Date:  2008-10       Impact factor: 5.310

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.